Argenx
ARGX
#579
Rank
โ‚น3.075 T
Marketcap
โ‚น50,288
Share price
0.77%
Change (1 day)
25.29%
Change (1 year)
Argenx is a Dutch company that develops antibody therapies to fight autoimmune diseases and cancer.

Market capitalization of Argenx (ARGX)

Market cap: โ‚น3.075 Trillion

As of November 2024 Argenx has a market cap of โ‚น3.075 Trillion. This makes Argenx the world's 579th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Argenx from 2014 to 2024

End of year Market Cap

Year Marketcap Change
2024โ‚น3.075 T63.68%
2023โ‚น1.878 T8.32%
2022โ‚น1.734 T26.7%
2021โ‚น1.368 T33.48%
2020โ‚น1.025 T109.06%
2019โ‚น490.51 B100.08%
2018โ‚น245.15 B91.51%
2017โ‚น128.01 B
2014โ‚น9.22 B

End of Day market cap according to different sources

On Nov 9th, 2024 the market cap of Argenx was reported to be:

โ‚น3.007 Trillion
by Yahoo Finance info icon info icon
โ‚น3.075 Trillion
by CompaniesMarketCap info icon info icon
โ‚น2.976 Trillion
by Nasdaq info icon info icon